CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia
about
The regulation of inflammatory pathways and infectious disease of the cervix by seminal fluidCpG sites associated with cigarette smoking: analysis of epigenome-wide data from the Sister StudyDifferential expression of GPR15 on T cells during ulcerative colitis.The variable loop 3 in the envelope glycoprotein is critical for the atypical coreceptor usage of an HIV-1 strain.Inference of surface membrane factors of HIV-1 infection through functional interaction networks.Potent and broadly reactive HIV-2 neutralizing antibodies elicited by a vaccinia virus vector prime-C2V3C3 polypeptide boost immunization strategy.Toll-like receptor 3 signalling up-regulates expression of the HIV co-receptor G-protein coupled receptor 15 on human CD4+ T cells.Increased frequency of circulating CCR5+ CD4+ T cells in human immunodeficiency virus type 2 infectionIn vitro phenotypic susceptibility of HIV-2 clinical isolates to CCR5 inhibitors.Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates.Efficient Nef-mediated downmodulation of TCR-CD3 and CD28 is associated with high CD4+ T cell counts in viremic HIV-2 infectionCigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome.Ethnicity and Smoking-Associated DNA Methylation Changes at HIV Co-Receptor GPR15Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection.The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals.Protective immunity against HIV infection: lessons from HIV-2 infection.Regulation of inflammatory pathways in cancer and infectious disease of the cervixVirus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype.International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.Antiretroviral drug resistance in human immunodeficiency virus type 2.A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support.HIV-2 A-subtype gp125c₂-v₃-c₃ mutations and their association with CCR5 and CXCR4 tropism.Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic tool.Identification of novel dioxin-responsive genes by representational difference analysis.CXCR6 gene characterization in two ethnically distinct South African populations and association with viraemic disease control in HIV-1-infected black South African individuals.Phosphorylation-dependent C-terminal binding of 14-3-3 proteins promotes cell surface expression of HIV co-receptor GPR15.CCR5 expression is elevated in cervical cancer cells and is up-regulated by seminal plasma.The Effect of Different Case Definitions of Current Smoking on the Discovery of Smoking-Related Blood Gene Expression Signatures in Chronic Obstructive Pulmonary Disease.Differential phosphorylation signals control endocytosis of GPR15Natural killer cell memory.
P2860
Q27024447-B109A83F-3D34-427A-B228-FFB5889C6547Q30794295-49D5294A-1C3D-4098-B762-E124E22503CBQ33579024-B449D443-638D-4D82-BF92-638FE1171663Q33711710-538C2799-B272-48FE-9E9C-1C56C4D68622Q33725721-D15B620A-F605-4DE0-B68F-C6C419961A56Q34290973-DD9B66EB-1D23-402F-858C-05015429A3FCQ35099526-FE344FA9-0746-4781-A551-31AE92760B43Q35185919-FDA358B0-86F4-4854-A1CF-ACDC3F5D5163Q35666480-CFF2B6FF-6053-43C0-BC8D-4E4F7FC45E5BQ35738681-12B0E167-37E1-43F5-BF56-0D35340A3ACEQ35943789-7ADE7224-243F-4F6B-990D-146B72DC464CQ36026933-96B35849-F45F-414E-868E-C7C6A6052E77Q36097654-82E4E8DC-32F0-4F41-9529-47F18E5BB39DQ36315149-651AF6B8-14F3-40BC-AB2C-988CFAA6CBB3Q36690419-6BAF004E-288F-4CC3-8B42-A91BB8B3D1A5Q36895619-955F8BA7-F6CD-4D55-BDA6-D28D86F9AB43Q37288090-42C04657-9B71-4E18-BC45-C4494CE57179Q37333754-9ED1EC96-2202-49B6-B94B-94F47ACF3A86Q37432097-97F5DCF5-281A-40BD-9F36-CFB2F0BFCBFFQ37496287-C3422F53-F78A-4FBF-9D00-BEDE409DCCE6Q37517645-E45C6460-5B20-415B-9C14-C58612F21C1EQ38973555-C84C10FF-98D4-495A-9850-7FE91F87FCECQ39433148-CBC3C888-96DF-41DA-9013-737BD6883DF7Q40108569-305935B2-2312-48A8-ABD9-686D512C2167Q40233843-4F5EE731-E394-4A49-A827-77ED7745E550Q41955759-BB3E6FE9-98EB-4AFB-B23E-A7EF3DC1D365Q42202724-9E62B294-E86C-4D1E-866C-C897412DB522Q42369040-9CB7ADC4-8546-40BC-97CB-3D51F8B7DBF2Q42712411-AFBDE51E-E04B-48E8-9D06-2C36965EB7E1Q51000689-7FCB4C5E-04BE-4080-A95C-12E34875BF59
P2860
CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
CCR5, GPR15, and CXCR6 are maj ...... ith and without plasma viremia
@ast
CCR5, GPR15, and CXCR6 are maj ...... ith and without plasma viremia
@en
CCR5, GPR15, and CXCR6 are maj ...... ith and without plasma viremia
@nl
type
label
CCR5, GPR15, and CXCR6 are maj ...... ith and without plasma viremia
@ast
CCR5, GPR15, and CXCR6 are maj ...... ith and without plasma viremia
@en
CCR5, GPR15, and CXCR6 are maj ...... ith and without plasma viremia
@nl
prefLabel
CCR5, GPR15, and CXCR6 are maj ...... ith and without plasma viremia
@ast
CCR5, GPR15, and CXCR6 are maj ...... ith and without plasma viremia
@en
CCR5, GPR15, and CXCR6 are maj ...... ith and without plasma viremia
@nl
P2093
P2860
P921
P1433
P1476
CCR5, GPR15, and CXCR6 are maj ...... ith and without plasma viremia
@en
P2093
A D M E Osterhaus
H Schuitemaker
M E van der Ende
P H M Boers
P2860
P304
P356
10.1128/JVI.79.3.1686-1700.2005
P407
P577
2005-02-01T00:00:00Z